Absence_NN
of_IN
T-cell_NN
-_:
and_CC
B-cell-specific_JJ
transcription_NN
factors_NNS
TCF-1_NN
,_,
GATA-3_NN
,_,
and_CC
BSAP_NN
in_IN
Hodgkin_NN
's_POS
Reed-Sternberg_NN
cells_NNS
._.

Based_VBN
on_IN
the_DT
presence_NN
of_IN
T_NN
cell_NN
receptor-beta_NN
-LRB-_-LRB-
TcR-beta_NN
-RRB-_-RRB-
gene_NN
rearrangements_NNS
in_IN
L428_NN
and_CC
HDLM-1_NN
cells_NNS
,_,
the_DT
expression_NN
of_IN
CD2_NN
in_IN
HDLM-1_NN
cells_NNS
,_,
and_CC
the_DT
presence_NN
of_IN
immunoglobulin_NN
heavy-chain_NN
-LRB-_-LRB-
IgH_NN
-RRB-_-RRB-
gene_NN
rearrangement_NN
in_IN
KM-H2_NN
cells_NNS
,_,
some_DT
researchers_NNS
have_VBP
concluded_VBN
that_IN
these_DT
long-term_JJ
cell_NN
lines_NNS
derived_VBN
from_IN
patients_NNS
with_IN
Hodgkin_NN
's_POS
disease_NN
are_VBP
lymphoid_JJ
in_IN
nature_NN
._.

The_DT
information_NN
obtained_VBN
from_IN
these_DT
cell_NN
lines_NNS
has_VBZ
also_RB
been_VBN
used_VBN
in_IN
arguments_NNS
for_IN
a_DT
lymphoid_JJ
origin_NN
of_IN
H-RS_NN
cells_NNS
in_IN
tissue_NN
despite_IN
the_DT
frequent_JJ
absence_NN
of_IN
lymphoid_JJ
markers_NNS
and_CC
Ig\/TcR_NN
gene_NN
rearrangements_NNS
in_IN
these_DT
cells_NNS
._.

We_PRP
questioned_VBD
whether_IN
one_PRP
can_MD
use_VB
the_DT
limited_JJ
expression_NN
of_IN
lymphoid_JJ
markers_NNS
or_CC
the_DT
limited_JJ
gene_NN
rearrangement_NN
to_TO
conclude_VB
that_IN
H-RS_NN
cells_NNS
have_VBP
a_DT
lymphoid_JJ
origin_NN
,_,
because_IN
these_DT
markers_NNS
may_MD
be_VB
aberrant_JJ
in_IN
tumor_NN
cells_NNS
._.

In_IN
this_DT
study_NN
,_,
we_PRP
examined_VBD
the_DT
expression_NN
of_IN
two_CD
T-cell-specific_JJ
transcription_NN
factors_NNS
-LRB-_-LRB-
TCF-1_NN
and_CC
GATA-3_NN
-RRB-_-RRB-
and_CC
one_CD
B-cell-specific_JJ
transcription_NN
factor_NN
-LRB-_-LRB-
BSAP_NN
-RRB-_-RRB-
in_IN
cultured_VBN
H-RS_NN
cells_NNS
by_IN
using_VBG
a_DT
gel_NN
mobility_NN
shift_NN
assay_NN
._.

The_DT
sensitivity_NN
and_CC
specificity_NN
of_IN
this_DT
assay_NN
for_IN
determination_NN
of_IN
cell_NN
lineage_NN
have_VBP
been_VBN
established_VBN
in_IN
a_DT
large_JJ
number_NN
of_IN
cultured_VBN
human_JJ
and_CC
murine_JJ
cell_NN
lines_NNS
._.

All_DT
three_CD
types_NNS
of_IN
H-RS_NN
cell_NN
lines_NNS
were_VBD
consistently_RB
negative_JJ
for_IN
BSAP_NN
,_,
TCF-1_NN
,_,
and_CC
GATA-3_NN
._.

The_DT
absence_NN
of_IN
GATA-3_NN
was_VBD
confirmed_VBN
in_IN
H-RS_NN
cells_NNS
in_IN
tissues_NNS
by_IN
an_DT
in_FW
situ_FW
hybridization_NN
technique_NN
._.

Virtually_RB
all_DT
B-cell_NN
lines_NNS
,_,
with_IN
the_DT
exception_NN
of_IN
some_DT
myeloma_NN
cell_NN
lines_NNS
,_,
are_VBP
positive_JJ
for_IN
BSAP_NN
,_,
which_WDT
is_VBZ
the_DT
transcription_NN
factor_NN
for_IN
promoters_NNS
for_IN
several_JJ
B-cell_NN
markers_NNS
,_,
including_VBG
VpreB1_NN
,_,
lambda_NN
5_CD
,_,
CD19_NN
,_,
and_CC
CD20_NN
._.

All_DT
T-cell_NN
lines_NNS
tested_VBN
were_VBD
positive_JJ
for_IN
TCF-1_NN
and_CC
GATA-3_NN
,_,
which_WDT
are_VBP
the_DT
transcription_NN
factors_NNS
for_IN
promoters_NNS
for_IN
several_JJ
T-cell-restricted_JJ
markers_NNS
,_,
including_VBG
CD2_NN
,_,
CD3_NN
,_,
TcR_NN
,_,
and_CC
lck_NN
._.

The_DT
absence_NN
of_IN
BSAP_NN
,_,
TCF-1_NN
,_,
and_CC
GATA-3_NN
clearly_RB
indicates_VBZ
an_DT
underlying_VBG
difference_NN
between_IN
H-RS_NN
cells_NNS
and_CC
lymphoid_JJ
cells_NNS
._.

